Senju-USA Inc.

Senju-USA Inc.

Senju USA, Inc is an ophthalmic pharmaceutical company aiming to develop unique and innovative products to treat various eye diseases....

Senju-USA Inc.'s Basic Information

Industry
Pharmaceutical Manufacturing
Headquarters
Osaka, Ōsaka, Japan
Headcount
2 - 10

Senju-USA Inc.'s Competitors

WuXi AppTec China
WuXi AppTec China

Shanghai, China

AISSMS College of Pharmacy - India
AISSMS College of Pharmacy - India

Arrow ART Finishers
Arrow ART Finishers

Insight Biopharma Consultancy CO LTD
Insight Biopharma Consultancy CO LTD

SYNERGY BIOLOGICS LIMITED
SYNERGY BIOLOGICS LIMITED

Walsall, England, United Kingdom

Employee Insights

Employee Function

Employee Location

Senju-USA Inc.'s Top Employees

people
Takahiro Ogawa
Senior Vice President
people
Takemasa Sugioka
Director, Licensing
people
Hitomi Kawawa
Manager OF Clinical Development
people
Saori Kato
Clinical Development Manager
people
Takenori Matsuda
Manager

Find Your Next Customer with Better Data

Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.

Top-ranked on G2 Crowd
🛡️GDPR compliantCancel anytime
Free credits every month!

Frequently Asked Questions Regarding Senju-USA Inc.

Where is Senju-USA Inc.'s headquarter located?

Senju-USA Inc.'s headquarter are located at Japan.

How many employees does Senju-USA Inc. have?

Senju-USA Inc. has 2 - 10 employees.

What is Senju-USA Inc.'s official website?

Senju-USA Inc.'s official website is http://senju-usa.com

What industry does Senju-USA Inc. belong to?

Senju-USA Inc. is in the industry of Pharmaceutical Manufacturing

What does Senju-USA Inc. do?

Senju USA, Inc is an ophthalmic pharmaceutical company aiming to develop unique and innovative products to treat various eye diseases....

Connect with anyone with AroundDeal today!

Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
cta